Patterns of response to anti-PD1 treatment: Comparison of three radiological response criteria and effect on overall survival (OS) in metastatic melanoma patients (MM)

被引：0
|
作者：
Kibiro, Minnie
Khoja, Leila
Hogg, David
Butler, Marcus O.
Metser, Ur
Atenafu, Eshetu G.
Joshua, Anthony M.
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9073
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients
    Khoja, Leila
    Kibiro, Minnie
    Metser, Ur
    Gedye, Craig
    Hogg, David
    Butler, Marcus O.
    Atenafu, Eshetu G.
    Joshua, Anthony M.
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1186 - 1192
  • [2] Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients
    Leila Khoja
    Minnie Kibiro
    Ur Metser
    Craig Gedye
    David Hogg
    Marcus O Butler
    Eshetu G Atenafu
    Anthony M Joshua
    British Journal of Cancer, 2016, 115 : 1186 - 1192
  • [3] The impact of clinical response to anti-CTLA4 treatment on overall survival (OS) in metastatic melanoma (MM).
    Feng, Xiaolan
    Smylie, Michael
    Cheng, Tina
    Monzon, Jose Gerard
    Lee-Ying, Richard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [5] PERFORMANCE STATUS AS A PREDICTOR OF RESPONSE TO ANTI-PD1 FOR METASTATIC MELANOMA
    Wong, A.
    Williams, M.
    Milne, D.
    Morris, K.
    Lau, P.
    Spruyt, O.
    Fullerton, S.
    McArthur, G.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 71 - 71
  • [6] Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma
    Tumeh, Paul Camille
    Rosenblum, Michael
    Handley, Nathan
    Tsai, Katy
    Rodriguez, Robert S. Rodriguez
    Khurana, Niharika
    Harview, Christina
    Spasic, Marko
    Sanchez, Phillip J.
    Chang, Jeremy
    Shintaku, I. Peter
    Taylor, Emma
    Chmielowski, Bartosz
    Grogan, Tristan
    Elashoff, David A.
    Pierce, Robert H.
    Daud, Adil
    CANCER RESEARCH, 2015, 75
  • [7] "Interchangeability" of anti-PD1 antibodies in patients (pts) with metastatic melanoma (mM)
    Kravchuk, Darya
    Fedyanin, Mikhail
    Rays, Anastasia
    Moiseenko, Fedor Vladimirovich
    Ivanilov, Kirill
    Popov, Vladimir
    Glazkova, Elena
    Chubenko, Viacheslav
    Levchenko, Evgeny
    Volkov, Nikita
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] LESION-SPECIFIC PATTERNS OF RESPONSE AND PROGRESSION WITH ANTI-PD-1 TREATMENT IN METASTATIC MELANOMA (MM)
    Lyle, M.
    Lee, J.
    Menzies, A. M.
    Chan, M. M. K.
    Clements, A.
    Carlino, M. S.
    Kefford, R.
    Long, G. V.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 63 - 63
  • [9] Mechanisms of response to anti-PD1 (PD1) combined with Ipilimumab (IPI) in patients (pts) with PD1-resistant metastatic melanoma (MM)
    da Silva, Ines Pires
    Conway, Jordan
    Edwards, Jarem
    Marsh-Wakefield, Felix
    Quek, Camelia
    Ferguson, Angela
    Johnansson, Peter
    Carlino, Matteo
    Menzies, Alexander
    Wilmott, James
    Palendira, Umaimainthan
    Scolyer, Richard
    Long, Georgina
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Lesion-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma (MM).
    Lyle, Megan Kate
    Lee, Jenny H. J.
    Menzies, Alexander M.
    Chan, Matthew M. K.
    Clements, Arthur
    Carlino, Matteo S.
    Kefford, Richard
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345